Gastroenterology & Endoscopy News

Gastroenterology & Endoscopy News No. 1–rated independent monthly newspaper providing news and information for 18,000+ gastroenterologists, colorectal surgeons, hepatologists, PAs and NPs.

Operating as usual

An online series introduces people with IBD to yoga, meditation and breathing exercises to help relieve symptoms.
07/17/2020
IBD Patients Can Learn Yoga From The Internet to Help Relieve Symptoms

An online series introduces people with IBD to yoga, meditation and breathing exercises to help relieve symptoms.

An online video and audio series aims to introduce people with inflammatory bowel disease to yoga, meditation and breathing exercises from the comfort of their own homes.

Up to 80% of people with IBD should receive infliximab in shorter intervals than is conventionally administered.
07/17/2020
Dashboard-Guided Infliximab Induction Dosing Improves Drug Concentrations

Up to 80% of people with IBD should receive infliximab in shorter intervals than is conventionally administered.

Up to 80% of people with inflammatory bowel disease should receive infliximab in shorter intervals than is conventionally administered, starting during induction, new research shows.

The Scope: Michael Weinstein, MD, talks about how to turn battleships during the pandemic, and what the future looks lik...
07/16/2020
The Scope: Michael Weinstein, MD, of Capital Digestive Care

The Scope: Michael Weinstein, MD, talks about how to turn battleships during the pandemic, and what the future looks like for GI groups.

Michael Weinstein, MD, the president of Capital Digestive Care in Washington, D.C., on how to turn battleships during the pandemic. 

Why do polyp detection rates vary so dramatically across VA centers?
07/15/2020
Polyp Detection Varies Dramatically Across VA Centers

Why do polyp detection rates vary so dramatically across VA centers?

Why would endoscopists at one veterans hospital have a polyp detection rate of only 18%, whereas those at another one boast a 73% rate—a fourfold difference? That’s a question raised by a study submitted to the 2020 Digestive Disease Week (abstract Mo1600).

In this episode of The Scope, Michael Weinstein, MD, the president of Capital Digestive Care talks about how to turn bat...
07/15/2020
The Scope: Michael Weinstein, MD, of Capital Digestive Care

In this episode of The Scope, Michael Weinstein, MD, the president of Capital Digestive Care talks about how to turn battleships during the pandemic, and what the future looks like for GI groups.

Michael Weinstein, MD, the president of Capital Digestive Care in Washington, D.C., on how to turn battleships during the pandemic. 

The rise of the GI hospitalist.
07/14/2020
The Rise of the GI Hospitalist

The rise of the GI hospitalist.

In a 1996 article in The New England Journal of Medicine, Robert M. Wachter, MD, and Lee Goldman, MD, predicted that the ascendance of managed care and its demands for efficiency would spur a “new breed” of physicians called “hospitalists,” who would transform the American he...

For patients with atrial fibrillation, GI bleeding may not be just a side effect of blood-thinning medications.
07/13/2020
Don’t Overlook CRC in Patients With AFib

For patients with atrial fibrillation, GI bleeding may not be just a side effect of blood-thinning medications.

For patients with atrial fibrillation, bloody stool may not be just a side effect of blood-thinning medications.

The debates commence with two diametrically opposed views on whether or not laparoscopy can be safely used in patients i...
07/13/2020
On the Spot: Debates in Colorectal Surgery 2020

The debates commence with two diametrically opposed views on whether or not laparoscopy can be safely used in patients infected with COVID19.

This year’s debates commence with two diametrically opposed views on whether or not laparoscopy can be safely used in patients infected with COVID-19.

Those who reported using PPIs twice a day were nearly 4x as likely to test positive for the SARS-CoV-2 virus.
07/10/2020
Use of PPIs Linked to Contracting COVID-19

Those who reported using PPIs twice a day were nearly 4x as likely to test positive for the SARS-CoV-2 virus.

People who take proton pump inhibitors for gastric reflux may be at increased risk for contracting the virus that causes COVID-19, new research shows. 

On the Spot: Debates in colorectal surgery 2020.
07/10/2020
On the Spot: Debates in Colorectal Surgery 2020

On the Spot: Debates in colorectal surgery 2020.

This year’s debates commence with two diametrically opposed views on whether or not laparoscopy can be safely used in patients infected with COVID-19.

The U.S. Food and Drug Administration approved Keytruda Merck the first immunotherapy approved as first-line monotherapy...
07/09/2020
First PD-1 Agent OK'ed for Initial MonoRx for Some Patients With Advanced CRC

The U.S. Food and Drug Administration approved Keytruda Merck the first immunotherapy approved as first-line monotherapy for patients with CRC.

The FDA approved pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair–deficient (dMMR) colorectal cancer (CRC). This is the first immunotherapy approved for this patient population as...

What’s not to love about disposable endoscopic devices?
07/09/2020
What’s Not to Love About Disposable Endoscopic Devices?

What’s not to love about disposable endoscopic devices?

Disposable endoscopic devices may be good for infection control, but they are not good for the environment according to a Dartmouth study that quantified the environmental impact of endoscopic waste.

In Part 2 of the two-part edition of The Regueiro Report, Miguel Regueiro, MD, highlights several abstracts submitted to...
07/08/2020
The Regueiro Report: More From DDW 2020

In Part 2 of the two-part edition of The Regueiro Report, Miguel Regueiro, MD, highlights several abstracts submitted to the 2020 Digestive Disease Week.

In Part 2 of the two-part edition of The Regueiro Report, Miguel Regueiro, MD, a professor of medicine and the chair of the Department of Gastroenterology, Hepatology and Nutrition at Cleveland Clinic in Cleveland, highlights several abstracts submitted to the 2020 Digestive Disease Week.

People who take PPIs for gastric reflux may be at increased risk for contracting COVID-19.
07/07/2020
Use of PPIs Linked to Contracting COVID-19

People who take PPIs for gastric reflux may be at increased risk for contracting COVID-19.

People who take proton pump inhibitors for gastric reflux may be at increased risk for contracting the virus that causes COVID-19, new research shows. 

Disposable endoscopic devices may be good for infection control, but they are not good for the environment.
07/06/2020
What’s Not to Love About Disposable Endoscopic Devices?

Disposable endoscopic devices may be good for infection control, but they are not good for the environment.

Disposable endoscopic devices may be good for infection control, but they are not good for the environment according to a Dartmouth study that quantified the environmental impact of endoscopic waste.

The Scope: Scott Fraser joins us again to talk about how GI practices can leverage their EHR systems, and offers more su...
07/01/2020
The Scope: How Practices Can Survive, and Thrive, in the COVID-19 ERA

The Scope: Scott Fraser joins us again to talk about how GI practices can leverage their EHR systems, and offers more survival tips in the COVID-19 era.

Endoscopy consultant Scott Fraser joins us again to talk about how GI practices can leverage their EHR systems into a revenue stream, and offers more survival tips for the pandemic era.   

For better clinical trials, engage patients.
07/01/2020
For Better Clinical Trials, Engage Patients

For better clinical trials, engage patients.

Sandra Zelinsky is an expert patient. Diagnosed with Crohn’s disease at age 19, and breast cancer in 2019 at 36, Ms. Zelinsky has been living with life-altering illnesses for more than a quarter-century.

Initiating colorectal cancer screening starting at 40 years of age is cost-effective.
06/30/2020
CRC Screening at Age 40 Seen Cost-Effective

Initiating colorectal cancer screening starting at 40 years of age is cost-effective.

Initiating colorectal cancer screening starting at 40 years of age is cost-effective, a new study has found.

Patient navigators boost diagnostic follow-up after positive FIT.
06/30/2020
Patient Navigators Boost Diagnostic Follow-up After Positive FIT

Patient navigators boost diagnostic follow-up after positive FIT.

The likelihood that people will complete diagnostic follow-up after a fecal immunochemical test comes back positive is increased by use of patient navigators, according to a program developed at the University of California, Los Angeles.

Is patient engagement the secret to better clinical trials?
06/29/2020
For Better Clinical Trials, Engage Patients

Is patient engagement the secret to better clinical trials?

Sandra Zelinsky is an expert patient. Diagnosed with Crohn’s disease at age 19, and breast cancer in 2019 at 36, Ms. Zelinsky has been living with life-altering illnesses for more than a quarter-century.

Initiating colorectal cancer screening starting at 40 years of age is cost-effective.
06/26/2020
CRC Screening at Age 40 Seen Cost-Effective

Initiating colorectal cancer screening starting at 40 years of age is cost-effective.

Initiating colorectal cancer screening starting at 40 years of age is cost-effective, a new study has found.

“Navigators increased the rate of diagnostic follow-up after a positive FIT by 32.5%.” Vivy Cusumano, MD.
06/26/2020
Patient Navigators Boost Diagnostic Follow-up After Positive FIT

“Navigators increased the rate of diagnostic follow-up after a positive FIT by 32.5%.” Vivy Cusumano, MD.

The likelihood that people will complete diagnostic follow-up after a fecal immunochemical test comes back positive is increased by use of patient navigators, according to a program developed at the University of California, Los Angeles.

The Scope: We speak with Elliot Newman, MD, about caring for cancer patients during the pandemic.
06/26/2020
Cancer and COVID-19: a Conversation With Elliot Newman, MD

The Scope: We speak with Elliot Newman, MD, about caring for cancer patients during the pandemic.

On this episode of The Scope, we speak with Elliot Newman, MD, the chief of surgical oncology, pancreas and hepatobiliary surgery at Lenox Hill Hospital, and a professor of surgery at the Zucker School of Medicine at Hofstra/Northwell, about caring for cancer patients during the pandemic. 

Could fecal microbiota transplants treat ulcerative colitis in children?
06/25/2020
Early FMT Trial Shows Potential for UC in Peds

Could fecal microbiota transplants treat ulcerative colitis in children?

Montreal—One of the first studies of its kind has found that serial fecal microbiota transplants in children with active ulcerative colitis led to greater improvements in serum and stool inflammatory markers as well as clinical response than did placebo.

Phase 2 data show long-term efficacy for Risankizumab in Crohn’s Disease.
06/25/2020
Phase 2 Data Show Long-Term Efficacy For Risankizumab in Crohn’s Disease

Phase 2 data show long-term efficacy for Risankizumab in Crohn’s Disease.

The interleukin (IL)-23 inhibitor risankizumab maintains long-term clinical and endoscopic remission in up to 77% of patients with Crohn’s disease who achieve remission with induction treatment, data from a phase 2, open-label study showed.

Patients with Crohn’s and ulcerative colitis might benefit most from patient engagement and care coordination to improve...
06/24/2020
The Cost Volatility of IBD, Quantified

Patients with Crohn’s and ulcerative colitis might benefit most from patient engagement and care coordination to improve outcomes and control costs.

What can the stock market teach gastroenterologists about the cost of inflammatory bowel disease? More than you might think.

Address

545 W 45th St
New York, NY
10036

Alerts

Be the first to know and let us send you an email when Gastroenterology & Endoscopy News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Gastroenterology & Endoscopy News:

Videos

Category

Nearby media companies


Comments

I'd like to introduce myself: I'm a volunteer patient advocate and the Vice President of the non profit group "Auto-Brewery Syndrome Information and Research Inc". A first ever book has been published on ABS and it's called "My Gut Makes Alcohol". Perhaps you've heard of it? I'm not here to sell anything, or solicit anything - I'm here to help spread awareness. Many members of our facebook support group have been misdiagnosed and accused of drinking, when they weren't. Many are also facing DUI criminal defenses and jail time. Feel free to see my husbands story below, and we will be appearing in the UK Newspaper The Guardian in a few weeks.
Doctors: Are you interested in an easy to look at, fun-to-read picture book that introduces the concept of a tube and then takes your patient through the inner workings of the digestive system. Common kid reaction: “Cool” Common adult /parent reaction: “I didn’t know all this” A fabulous tool for both marketing one’s practice as well as improving patient communication and education. Gift them to your patients. Leave them in your waiting room or exam rooms. Or for marketing and advertising, distribute them in other public waiting areas. Private Label Customizable Options available: Customizable Covers (front and back) Customizable Text Additional Text on existing pages Additional Customized pages Additional Customized illustrations Quantity Discounts For more information please visit: